Javelin Oncology is developing precision CART therapies for the treatment of cancer. Javelin is combining the power of precision patient matching with the curative potential of CARTs to create a pipeline of new, safer therapies to multiple targets. These therapies will be delivered through careful genetic screening in order to apply our proprietary patient selection algorithms and ensure delivery of our therapies only to patients who will respond. Javelin’s proprietary genetic stratification algorithms available to partners who want to maximize their CART investment and significantly shorten clinical development time.

Innovation Space:

Related Articles